Verdine Gregory L. 4
4 · Wave Life Sciences Ltd. · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Verdine Gregory L.
Director
Transactions
- Exercise/Conversion
Share Option (right to buy)
2025-03-05−133,000→ 133,402 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (133,000 underlying) - Exercise/Conversion
Ordinary Shares
2025-03-05$2.48/sh+133,000$329,840→ 179,155 total - Exercise/Conversion
Ordinary Shares
2025-03-07$2.48/sh+133,402$330,837→ 312,517 total - Exercise/Conversion
Share Option (right to buy)
2025-03-07−133,402→ 0 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (133,402 underlying)
Footnotes (1)
- [F1]The share options that were exercised via cash purchase in this reportable transaction were fully vested.